Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2025-12-24 @ 2:13 PM
NCT ID:
NCT05742295
Eligibility Criteria:
Inclusion Criteria:
* ICU admitted patients on treatment or prophylactic doses of cefoperazone/sulbactam.
Exclusion Criteria:
* Patients' aged \<18 years
* Pregnancy or breastfeeding women
* Active bleeding or bleeding disorder
* Patients having an abnormal baseline coagulation profile.
* Patients administer total parenteral nutrition with regular vitamin k supplements.
* Refusal to sign the written informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05742295
Study Brief:
Protocol Section:
NCT05742295